Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2003
08/21/2003US20030157131 Interferon inducing genetically engineered attenuated viruses
08/21/2003US20030157130 Modified to include heterologous insertion downstream of its replicase open reading frames; insertion preferably comprises one or more protein-coding regions ideal for virus-like particles packaging
08/21/2003US20030157125 Composition containing leishmania lip2a
08/21/2003US20030157124 Chlamydia membrane ATPase and corresponding DNA molecules, which can be used to prevent and treat Chlamydia infection in mammals such as humans
08/21/2003US20030157123 Chlamydia membrane ATPase and corresponding DNA molecules, which can be used to prevent and treat Chlamydia infection in mammals such as humans
08/21/2003US20030157121 Virulence genes, proteins, and their use
08/21/2003US20030157120 Therapeutic compositions for treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism
08/21/2003US20030157118 Tumour-specific animal proteins
08/21/2003US20030157116 Tlp peptides and dna sequences coding the same
08/21/2003US20030157115 Carrier with a dendrimeric poly-Lysine enabling multiple epitopes to be covalently attached thereto, a peptide with t epitope(s) and a carbohydrate with a b epitope that is not a sialoside; immunotherapy
08/21/2003US20030157111 76A11 polypeptide and uses thereof
08/21/2003US20030157106 Antibody which immunologically reacts with an interleukin 22 protein
08/21/2003US20030157103 Human amine transporter antibodies
08/21/2003US20030157102 Administering a ligand having a population of activated t cells and binding specificity for the extracellular domain of CD28 to enhance t cell proliferation and increase overall lymphokine levels
08/21/2003US20030157101 Cytotoxic t-lymphocyte-epitopes from anaplastic lymphoma kinase (alk) protein; immunotherapy
08/21/2003US20030157099 Human trk receptors and neurotrophic factor inhibitors
08/21/2003US20030157098 Methods for inhibiting brain tumor growth
08/21/2003US20030157096 Used to antagonize the effects of T-cell inducible factor in certain diseases
08/21/2003US20030157095 Invasive and metastic ability of breast cancer cells is proportional to level of peripheral type benzodiazepine receptor expressed, correlates with subcellular localization in that it is found in the nucleus of aggressive tumor cells
08/21/2003US20030157090 Redox systems; accumulation of polypeptide in plant cell; genetic engineering
08/21/2003US20030157089 Polypeptides; inducting immunology response
08/21/2003US20030157076 Disruption of the Akt2 gene
08/21/2003US20030157075 Diabetes screening, therapy
08/21/2003US20030157072 Gene expression; cell differentiation; anticancer agents
08/21/2003US20030157070 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
08/21/2003US20030157069 Administering polypeptide; them radiation and drug therapy
08/21/2003US20030157065 Gene therapy; gene encoding drug metabolizing enzyme
08/21/2003US20030157059 Vaccine; infection therapy
08/21/2003US20030157056 Modified cytokines for use in cancer therapy
08/21/2003US20030157055 Modified cytokines for use in cancer therapy
08/21/2003US20030157022 Non-invasive localization of a light-emitting conjugate in a mammal
08/21/2003US20030155434 Spray nozzle apparatus and method of use
08/21/2003CA2816242A1 Signal for packaging of influenza virus vectors
08/21/2003CA2513198A1 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003CA2482633A1 Oligomeric molecules and uses thereof
08/21/2003CA2476561A1 Mouse spermatogenesis genes, human male sterility-associated genes and diagnostic system using the same
08/21/2003CA2476556A1 Modulation of immune response by non-peptide binding stress response polypeptides
08/21/2003CA2476292A1 Helical peptidomimetics
08/21/2003CA2476239A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003CA2476165A1 Mhc class i peptide epitopes from the human 5t4 tumor-associated antigen
08/21/2003CA2475972A1 Enzyme treatment of foodstuffs for celiac sprue
08/21/2003CA2475924A1 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
08/21/2003CA2475838A1 Cytotoxic t-cell epitopes from chlamydia
08/21/2003CA2475388A1 Chimeric molecules for cleavage in a treated host
08/21/2003CA2475373A1 Oligonucleotide analogues and methods of use for modulating gene expression
08/21/2003CA2475177A1 Materials and methods for preparing dimeric growth factors
08/21/2003CA2475102A1 Stabilized synthetic immunogen delivery systems
08/21/2003CA2474885A1 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003CA2472956A1 Formulation strategies in stabilizing peptides in organic solvents and in dried states
08/21/2003CA2452854A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/20/2003EP1336656A2 20 human secreted proteins
08/20/2003EP1336652A1 Cells to be used in producing virus vector, process for producing the same and process for producing virus vector with the use of the cells
08/20/2003EP1336621A2 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
08/20/2003EP1336619A2 Combination of a HVEM-LIGHT inhibitor and an immunosuppressive agent in the treatment or prevention of immune disorders
08/20/2003EP1336617A2 Conotoxins having acetylcholin receptor binding properties
08/20/2003EP1336616A1 Activated peptides and conjugates
08/20/2003EP1336409A1 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders
08/20/2003EP1335987A2 Modified vaccinia ankara virus variant
08/20/2003EP1335986A2 Phosphatase stress-related proteins and methods of use in plants
08/20/2003EP1335980A2 Nucleotide sequences coding for the cysq gene
08/20/2003EP1335979A2 Herbicide target genes and methods
08/20/2003EP1335978A2 Regulation of human extracellular calcium-sensing g protein-coupled receptor
08/20/2003EP1335977A2 Human v2 vomeronasal receptor
08/20/2003EP1335976A2 Modifier of organelle metalbolism
08/20/2003EP1335975A2 "47324", a human g-protein and uses therefor
08/20/2003EP1335938A2 Apolipoprotein analogues
08/20/2003EP1335937A2 Mixed fibrils
08/20/2003EP1335935A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant
08/20/2003EP1335934A1 Gene encoding protein cluster i and the encoded protein
08/20/2003EP1335933A2 Pna analogues
08/20/2003EP1335932A1 Isolation of lectins
08/20/2003EP1335931A2 Derivatisation of proteins in aqueous solution
08/20/2003EP1335920A2 Small molecule compositions for binding to hsp90
08/20/2003EP1335752A1 Multipurpose packages for sterilised products or products to be sterilised
08/20/2003EP1335745A1 Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer
08/20/2003EP1335743A1 Inhibition or reversal of skin aging by actin-sequestering peptides
08/20/2003EP1335741A2 METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE
08/20/2003EP1335646A2 Transgenic or recombinant non-human mammals and their uses in screening psycho-active medicines
08/20/2003EP1147213A4 Novel rgs-containing molecules and uses thereof
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP1047711B1 Nucleic acid sequences encoding capsaicin receptors
08/20/2003EP0918548B1 Use of oxidized cellulose and complexes thereof for chronic wound healing
08/20/2003EP0868511B1 Utrophin gene expression
08/20/2003EP0837935B1 3' utr of the human prohibitin gene
08/20/2003EP0821003B1 Peptides and remedy for autoimmune diseases comprising the same
08/20/2003EP0817852B1 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
08/20/2003EP0721510B1 Anti-cancer gene therapy by modulation of immune or inflammatory response
08/20/2003EP0693938B1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
08/20/2003EP0672067B1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
08/20/2003EP0324789B1 Methods of regulating metabolic stability of proteins
08/20/2003CN1437655A Assembly of wild-type and chimeric influenza virus-like particles (VLPS)
08/20/2003CN1437654A Antigenic proteins of shrimp white spot syndrome virus uses thereof
08/20/2003CN1437653A Antigenic polypeptides
08/20/2003CN1437652A Compounds and methods for treatment and diagnosis of chlamydial infection
08/20/2003CN1437613A Modified morbillivirus V proteins
08/20/2003CN1437612A Nucleotide sequence of influenza A/Udorn/72(H3N2) genome
08/20/2003CN1437479A Recombinant intracellular pathogen vaccines and methods for use
08/20/2003CN1437476A Optimized minigenes and peptides encoded thereby
08/20/2003CN1437443A Hypersensitive response (HR)-elicitor to inhibit post harvest disease or desiccation of fruits or vegetables
08/20/2003CN1437442A Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological
1 ... 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 ... 2916